- $15.20bn
- $28.18bn
- $14.30bn
Annual income statement for Viatris, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 17,886 | 16,263 | 15,427 | 14,739 | 14,300 |
| Cost of Revenue | |||||
| Gross Profit | 6,560 | 7,033 | 6,732 | 6,138 | 5,655 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 17,928 | 14,652 | 14,685 | 15,342 | 17,066 |
| Operating Profit | -42 | 1,611 | 742 | -603 | -2,766 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -664 | 2,813 | 203 | -623 | -3,665 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -1,269 | 2,079 | 54.7 | -634 | -3,515 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -1,269 | 2,079 | 54.7 | -634 | -3,515 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -1,269 | 2,079 | 54.7 | -634 | -3,515 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.054 | 2.42 | 0.537 | 0.772 | -0.724 |
| Dividends per Share |